DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Esperion Therapeutics, Inc. (ESPR)
« Back to company indexESPR Chatter Timeline
Stock Ticker for ESPR
Most Active Tweeters for ESPR
No tweets foundRecent Tweets for ESPR
 |
@thejadedtrader RT @adamfeuerstein: What you need to know about the cholesterol trial that could swing billions $ESPR https://t.co/fueNyJ0xAZ via @damianga… August 22nd 2018, 3:08am |
 |
@EpiscopalianTra $ESPR I want to hear phase 3 data with reards to the Bempedoic Acid/ Ezetimibe (1002FDC-053) TODAY. Otherwise I am pulling out! August 21st 2018, 6:08pm |
 |
@tradnews_ RT @OpenOutcrier: $ESPR (+0.0% pre) What you need to know about the cholesterol trial that could swing billions - STAT https://t.co/mMTTlD… August 21st 2018, 12:08pm |
 |
@OpenOutcrier $ESPR (+0.0% pre) What you need to know about the cholesterol trial that could swing billions - STAT https://t.co/mMTTlDZLef August 21st 2018, 12:08pm |
 |
@adamfeuerstein What you need to know about the cholesterol trial that could swing billions $ESPR https://t.co/fueNyJ0xAZ via @damiangarde August 21st 2018, 12:08pm |
 |
@bibeypost_stock How Analysts Feel About Esperion Therapeutics, Inc. $ESPR After Forming Multiple Bottom? - https://t.co/quXU2ghP7M August 21st 2018, 11:08am |
 |
@reurope_stock Could Esperion Therapeutics, Inc. $ESPR Gain Strenght After Forming Multiple Bottom Chart Pattern? https://t.co/MenuI6RwhR August 21st 2018, 11:08am |
 |
@mmahotstuff1 It Seems Esperion Therapeutics, Inc. $ESPR Will Go Down. Formed A Few Months Multiple Bottom Chart Pattern - https://t.co/9SnVxXQ6Bt August 21st 2018, 11:08am |
 |
@whatsonthorold2 It Seems Esperion Therapeutics, Inc. $ESPR Will Go Down. Formed A Few Months Multiple Bottom Pattern - https://t.co/niOtqNBa2Y August 21st 2018, 11:08am |
 |
@west_moreland Is Selling Esperion Therapeutics, Inc. $ESPR Here a Winning Strategy? The Stock Formed Bearish Multiple Bottom Patt… https://t.co/z8dVVMz9mj August 21st 2018, 11:08am |
 |
@Fanob_stock What Next for Esperion Therapeutics, Inc. $ESPR After Forming Bearish Multiple Bottom? https://t.co/fGuFND1ah2 August 21st 2018, 11:08am |
 |
@statnews STAT Plus: What you need to know about the cholesterol trial that could swing billions. $ESPR https://t.co/2xsS2QKUdi August 21st 2018, 9:08am |
 |
@WatchlistN Esperion Therapeutics $ESPR Upgraded at Citigroup https://t.co/zPVZAfxq5d August 21st 2018, 8:08am |
 |
@langanstocks ESPR 47.97 Esperion Theraptc is number 27 out of 100 Top trading stocks today. $ESPR -0.15 -0.31% 100 day aver https://t.co/3PFRGppQPG August 20th 2018, 2:08pm |
 |
@BoardCentral $ESPR "ESPR my hope for today" on The Motley Fool message boards: https://t.co/j7y46htwi1 August 20th 2018, 11:08am |
 |
@QuantchaIdeas Covered Call Alert: ESPERION THERAPEUTICS INC. CO $ESPR returning up to 48.64% through 18-Jan-2019… https://t.co/C7Wepuc8Jm August 20th 2018, 10:08am |
 |
@FZucchi RT @alanhobbes: @AlanHobbes Update on #Esperion $ESPR, Just Days Before the Pivotal Trial Results - https://t.co/rBuZvUnRpL August 20th 2018, 7:08am |
 |
@1MinuteStock We calculated 21-day Expected Return of $ESPR for you: 12.15% https://t.co/FHEq5UVXB1 August 20th 2018, 5:08am |
 |
@TickerReport Esperion Therapeutics $ESPR Raised to “Buy” at Citigroup https://t.co/0JL4tvTjPe August 20th 2018, 5:08am |
|
@1MinuteStock Do you know that #WallStreet price for $ESPR is $61.23 https://t.co/TdsJGUvSE7 August 20th 2018, 5:08am |
|
@1MinuteStock Unicorn Bay rating for $ESPR is 2.66 out of 5. https://t.co/VhmCSHU6DS August 20th 2018, 5:08am |
|
@1MinuteStock Wondering about risks of $ESPR? The 63-day volatility is 24.61% https://t.co/fepyonl7yK August 20th 2018, 3:08am |
 |
@alanhobbes @AlanHobbes Update on #Esperion $ESPR, Just Days Before the Pivotal Trial Results - https://t.co/rBuZvUnRpL August 20th 2018, 3:08am |
 |
@Grolden87 $ESPR on watch. https://t.co/22gTxiZGmi August 20th 2018, 1:08am |
 |
@AjAwesomecalls $ESPR This was so easy it was such a lay up SHORT, this caught an upgrade from #Citi, but you had to read it to und… https://t.co/oG3RUzJjoY August 19th 2018, 3:08pm |
 |
@dakotafinancial Esperion Therapeutics Inc $ESPR Expected to Announce Earnings of -$1.60 Per Share https://t.co/aX0jXPnLbk August 19th 2018, 1:08pm |
 |
@ZolmaxNews Esperion Therapeutics Inc $ESPR Expected to Announce Earnings of -$1.60 Per Share https://t.co/8KbiTaUTjw August 19th 2018, 1:08pm |
 |
@MareaInformativ Esperion Therapeutics $ESPR Given Daily Media Impact Score of 0.07 https://t.co/QnA8LJywZ9 August 19th 2018, 11:08am |
|
@dakotafinancial Esperion Therapeutics $ESPR Upgraded to “Buy” at Citigroup https://t.co/EiOl8MQZAL August 19th 2018, 7:08am |
 |
@registrarjourn Esperion Therapeutics $ESPR Upgraded by Zacks Investment Research to Hold https://t.co/TQObATsQ5B August 19th 2018, 12:08am |
 |
@EnterpriseLeade Esperion Therapeutics $ESPR Upgraded by Zacks Investment Research to Hold https://t.co/flsKhGCzkx August 19th 2018, 12:08am |
 |
@pennyomegaCRWE $ESPR upgraded to Buy from Neutral at Citi https://t.co/GUkC37QuVw https://t.co/4OtxNaYzFd August 18th 2018, 2:08pm |
|
@ZolmaxNews Esperion Therapeutics $ESPR Upgraded at Citigroup https://t.co/1rqjV67PRc August 18th 2018, 1:08pm |
 |
@dailypoliticaln Esperion Therapeutics $ESPR Upgraded to “Buy” at Citigroup https://t.co/1AAPs86THB August 18th 2018, 1:08pm |
 |
@The_CasualSmart Partner Fund Management LP Boosted Its Esperion Therapeutics Ne $ESPR Position; Shorts at WISEKEY INTERNATIONAL HOL… https://t.co/MvVPYr5Wz1 August 18th 2018, 1:08pm |
 |
@ConsumerFeed Esperion Therapeutics Inc $ESPR Receives $84.05 Average PT from Analysts https://t.co/nEWjlRruSn August 18th 2018, 11:08am |
 |
@usindexlive Esperion Therapeutics $ESPR Holder Meditor Group LTD Upped Its Holding; Premier Asset Managment Increases Position… https://t.co/dQ9QGfaRWL August 18th 2018, 8:08am |
 |
@wcm_matt Buying the $espr dip at ~$42 has been playing out well, institutions and insiders didn’t sell shares after the drop… https://t.co/vye8N4o6ni August 17th 2018, 6:08pm |
|
@BoardCentral $ESPR "tender offer" on The Motley Fool message boards: https://t.co/SFwYpfcTae August 17th 2018, 6:08pm |
|
@bibeypost_stock Just How Positive is Citigroup on Esperion Therapeutics $ESPR Following Their Upgrade? - https://t.co/6z7vEE39eb August 17th 2018, 5:08pm |
|
@mmahotstuff1 Should Investors Be Buying Esperion Therapeutics $ESPR Stock Following Today’s Citigroup Upgrade? - https://t.co/PkK3Ot3x5F August 17th 2018, 5:08pm |
|
@reurope_stock Citigroup Gives Esperion Therapeutics $ESPR a Higher Rating. Raises its Neutral Rating https://t.co/AeXlmzFOsF August 17th 2018, 5:08pm |
|
@mmahotstuff1 What Will The Effects of a Citigroup Upgrade Be For Esperion Therapeutics $ESPR Shares? - https://t.co/8ekdgK6cyX August 17th 2018, 5:08pm |
|
@reurope_stock Esperion Therapeutics $ESPR Gets an Upgrade to a "Neutral" Rating https://t.co/KQwA3Gp0bj August 17th 2018, 5:08pm |
|
@whatsonthorold2 Esperion Therapeutics $ESPR Gets an Upgrade to a Neutral Rating - https://t.co/YIsFVuIQrr August 17th 2018, 5:08pm |
|
@whatsonthorold2 Are Esperion Therapeutics $ESPR Shares Headed North? Citigroup Issues Upgrade. - https://t.co/O7LoJPOFUW August 17th 2018, 5:08pm |
|
@west_moreland Should Investors Be Buying Esperion Therapeutics $ESPR Stock Following Today’s Citigroup Upgrade? https://t.co/BmUJYxGKA6 August 17th 2018, 5:08pm |
|
@west_moreland Citigroup Gives Esperion Therapeutics $ESPR a Higher Rating. Raises its Neutral Rating https://t.co/XF78J0qbS7 August 17th 2018, 5:08pm |
|
@Fanob_stock Esperion Therapeutics $ESPR Share Price May Be About to Change Direction; Citigroup Upgrades The Company. https://t.co/jZwcUzRKZS August 17th 2018, 5:08pm |
|
@Fanob_stock Esperion Therapeutics $ESPR Has Been Upgraded Today by Citigroup to a "Buy" https://t.co/NIFHN9lp9w August 17th 2018, 5:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.